Newsletter Signup | Join Community | Cancer Types
Lynparza is an effective treatment for women with newly diagnosed and recurrent BRCA + and other mutated ovarian cancers
Oct 2, 2019
Understand the symptoms, risk factors, diagnosis, tests and the role of screening and early detection of ovarian cancer.
May 9, 2019
Oct 23, 2019
Ovarian cancer symptoms, risk factors, and treatment
Jul 18, 2018
May 23, 2020
Experience, expertise, and specialization improve outcomes for women with ovarian, endometrial and cervical cancers.
May 1, 2020
Research suggests immunotherapy combination of Opdivo-Yervoy treatment is promising for ovarian cancer.
Jan 20, 2020
Does aspirin prevent ovarian cancer?
Jan 4, 2020
Anit-angiogenic - immunotherapy combination represents new treatment option for recurrent ovarian cancer.
Dec 30, 2019
Novel combination of sitravatinib and tislelizumab shows manageable safety and promising activity in phase Ib study
Dec 14, 2019
Maintenance therapy with Votrient delays cancer progression but does not appear to improve survival duration.
Dec 3, 2019
Understand the role of surgery, chemotherapy, and precision cancer medicines in the treatment of Ovarian Cancer.
Nov 29, 2019
Jan 14, 2020
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
Oct 14, 2019
PARPs and Avastin delay progression when used as maintenance therapy for certain individuals with ovarian cancer.
Oct 8, 2019
Dec 1, 2019
Understanding PARP inhibitor treatment in ovarian cancer - updated results from the Oct. ESMO 2019 meeting.
Apr 7, 2020
The PARP inhibitor Zejula is a precision cancer medicine that delays ovarian cancer progression and prolongs survival.
Learn how to qualify for SS benefits.
Sep 10, 2019
PARP Inhibitor Rubraca prolongs survival in ovarian fallopian tube & primary peritoneal cancers leading to FDA approval.
Sep 7, 2019
2019 saw the greatest changes in the management of ovarian cancer in 20 years - learn more.
Sep 6, 2019
Aug 6, 2019
Answers to frequently asked questions about Ovarian Germ Cell cancers
Sep 1, 2019
Answers to frequently asked questions about CA 125.
Aug 30, 2019
Apr 28, 2020
Combination of novel precision cancer medicines represents future direction of ovarian cancer treatment.
Jul 5, 2019
According to Lancet publication: PI3K - PARP inhibitor combination promising in ovarian cancer - future study warranted
Apr 2, 2019
Chemotherapy and maintenance therapy options for recurrent ovarian cancer.
Mar 25, 2019
Survival at 2 years was 72.4% versus 40.9% with chemotherapy alone
Mar 21, 2019
Stay Current With Ovarian Cancer Treatment Advances & Connect with Others
Feb 5, 2019
Hospital and surgeon experience contribute to lower mortality rates and better outcomes for ovarian cancer.
Dec 13, 2018
Oct 14, 2018
Looking for Long Term Survivors: https://www.massgeneral…
Sep 19, 2018
Great NOCC overview on maintenance therapy for ovarian cancer. https://www.youtube.com/watch…
Sep 14, 2018
Speak up and share your story of hope!